• PNM0206
  • NpFlamma® MMP-3,7 774
Cat. No. Packing Size Price($) Qty
PNM0206 10 doses on request
PNM0206 50 doses on request
PNM0206 199 doses on request
Information
NpFlamma® MMP-3,7 774
Synonyms
CAS number
M.F.
Mol. Wt.
Appearance Green Liquid
Purity
Certificate
Reference

Specifications

Application Type: In vivo

Fluorescent agent type: Activatable

Particle Size: 250±50nm

Fluorophore Label: Flamma® 774

Excitation/Emission (nm): 793 / 810 nm

Storage condition: 4°C protect from light



Information


Cancer cell is influenced by ECM (extracellular matrix), ECM-related growth factors and cytokine and surrounding cells in the growth process of cancer cell. Especially four characteristics of cancer such as migration, invasion, metastasis and angiogenesis react according to the surrounding micro environment. In this case, MMP (matrix metalloprotease) that is the protease controls cell-cell and cell-ECM interactions playing an important role in the growth of cancer cell. Accordingly a number of researches have been proceeding a variety of researches using MMP. As this product generates fluorescence according to the absolute volume of MMP, it can be effectively accumulated in the cancer tissues and it is possible for optical imaging of the tissues where MMP is over-expressed. As this product enables to quickly check activity and suppression of protease through imaging, which can be applied to drug screening, and it is possible for real-time based cell imaging and non-invasive tissues imaging for cell and tissue. Especially in addition to the method of screening new drug such as inhibitor that inhibits over-expression of protease, it can be used usefully for early diagnosis of a variety of diseases and incurable diseases like autoimmune diseases that are MMP-related cancer, ostarthritis, rheumarthritis, dementia, etc. In addition, this products group is expected to be easy to use owing to have various fluorescent wavelengths.

NpFlamma® MMP series of BioActs is a product developed to activate fluorescence depending on the types of MMP expressed in vivo. It is MMP activatable imaging agents that are completed by applying fluorescence technique of Flamma® Fluors and quencher technique of qFlamma® based on BioActs’ patented technology in peptides.




표 1. NpFlamma® MMPseries 제품 list


그림 1. NpFlamma® MMP Seires 의 작동 원리 및 Enzyme에 대한 높은 반응성 확인





그림 2. Trypsin 의 농도에 따른 NpFlamma MMP Seires 의 높은 형광 복원력 확인


그림 3. NpFlamma® MMP 제품과 타사 제품의 시간별 in-vivo 영상을 비교한 결과, 타 장기 대비 암 축적 효율이 높은 것을 확인하였음.


그림 4. NpFlamma® MMP 제품과 타사 제품의 24시간 후 장기 조직의 ex-vivo 영상을 비교한 결과, 타 장기 대비 암 축적 효율이 높은 것을 확인하였음


목록
QUICK
Recently Viewed